Q2 2019 Neurocrine Biosciences Inc Earnings Call Transcript
Hello, and thank you for joining the Neurocrine Biosciences Reports Second Quarter 2019 Results Call. (Operator Instructions) Please note, this call may be recorded.
(Operator Instructions)
It is now my pleasure to turn today's conference over to Kevin Gorman, CEO. Please go ahead.
Thank you very much, and thank you, everyone, for taking the time to join us on our Q2 earnings call. On this call, I'm joined by Kyle Gano, our Chief Strategy and Business Development Officer; Eiry Roberts, our Chief Medical Officer; Matt Abernethy, Chief Financial Officer; and Eric Benevich, Chief Commercial Officer.
Now during this call, we will all be making forward-looking statements. So Jane, could you please read our safe harbor statement.
Yes, good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |